GL1X · GenesisL1 explorer

MolNFT v1 · #155517 · protein

Cryo-EM structure of full echovirus 11 particle at pH 5.5

6LA4 · Capsid protein VP1: “Cryo-EM structure of full echovirus 11 particle at pH 5.5”. Electron microscopy, 1 ligand (SPH), 13 pockets (best druggability 0.78). MolNFT v1 #155517 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6LA4
Type
protein
Length
833 residues
Chains
4
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Capsid protein VP1; Capsid protein VP2; Capsid protein VP3; Capsid protein VP4
Ligands
SPH
Pockets
13 · best druggability 0.78

Structure

electron microscopy · 4 distinct chains · 9% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACapsid protein VP1protein2859% helix, 32% strand—
BCapsid protein VP2protein25110% helix, 38% strand—
CCapsid protein VP3protein2388% helix, 30% strand—
DCapsid protein VP4protein5912% helix, 17% strand—

Ligands and binding sites

  • SPH · Sphingosine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16020.780.8483SPH
2500.700.9816empty
3780.530.8628empty
41290.520.8130empty
51780.510.7828empty

Interfaces

6 interfaces between chains.

  • A–C · 4470 Ų buried · 57 hydrogen bonds · protein-protein
  • A–B · 2100 Ų buried · 25 hydrogen bonds · protein-protein
  • B–C · 1553 Ų buried · 14 hydrogen bonds · protein-protein
  • A–D · 1485 Ų buried · 18 hydrogen bonds · protein-protein
  • C–D · 924 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 6LA4 · Cryo-EM structure of full echovirus 11 particle at pH 5.5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.